NEW YORK and YANTAI, Shandong Province, China, April 21, 2011 (GLOBE NEWSWIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) (OTCQB:BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announced that it has retained Crescendo Communications, LLC (“Crescendo”) as its investor relations and corporate communications advisor to help broaden awareness of the company within the U.S. capital markets.
